Home
Scholarly Works
Sustained reversal of apixaban anticoagulation...
Conference

Sustained reversal of apixaban anticoagulation with andexanet alfa using a bolus plus infusion regimen in a phase 2 placebo controlled trial

Authors

Crowther M; Lu G; Conley P; Hollenbach S; Castillo J; Lawrence J; Barron L; Levy G; Connolly S; Curnutte J

Volume

35

Pagination

pp. 137-137

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2014

Name of conference

Annual Meeting of the European-Society-of-Cardiology (ESC)

Conference place

SPAIN, Barcelona

Conference start date

August 30, 2014

Conference end date

September 3, 2014

Conference proceedings

EUROPEAN HEART JOURNAL

ISSN

0195-668X

Contact the Experts team